METHODS: We consecutively enrolled patients with suspect drug allergy undergoing a drug challenge test preceded from the administration of the placebo. All patients underwent Hospital Anxiety and Depression Scale (HADS), a question to identify anxiety and depression, before the challenge test.
RESULTS: A total of 196 patients were enrolled into this study: sixteen (8.2%) resulted positive to HADS and 54 had at least one placebo reaction during drug provocation. There were statically significant correlations between HADS’ positivity and the finding of placebo-reaction (Fisher' exact test: p < 0.0001), and between the latter and a history of severe reactions to drug (Fisher' exact test: p < 0,0001).
CONCLUSIONS: There is a significant an strong correlation between the loss of psychic equilibrium and the development of placebo reaction during a drug provocation challenge. We suggest to use HADS or other validated questionnaire, in clinical practice before a drug challenge test in order to evaluate the possible psychiatric components.